Arqule

Cancer Cures: ASCO Stocks to Give Your Portfolio a Boost
Motley Fool
Sat, 03/24/12 - 11:30 am
Celldex
Arqule
JNJ
Ariad Pharmaceuticals
Aveo Pharmaceutical
7 Cancer Drug Stocks to Know Right Now
Seeking Alpha
Wed, 03/14/12 - 10:54 am
Seattle Genetics
Celldex
Arqule
Daiichi Sankyo
JNJ
Medivation
Dendreon
Aveo Pharmaceutical
Ariad Pharmaceuticals
AstraZeneca
Array Biopharma
Oncothyreon
ArQule license deal with Daiichi could land $265M
Bizjournals.com
Thu, 11/10/11 - 01:09 pm
Arqule
Daiichi Sankyo
kinase inhibitors
3 Clear Winners of ESMO 2010
Seeking Alpha
Mon, 10/25/10 - 10:35 am
ESMO
cancer
Aveo Pharmaceutical
Arqule
Dendreon
Immunogen
Roche
Medarex
Seattle Genetics
Sanofi
Pfizer Failure Clears Way for Small Biotech ArQule
Minyanville
Tue, 08/24/10 - 01:48 pm
Pfizer
Sutent
Arqule
small cell lung cancer
ArQule: Warming Up or Cooling Off?
Motley Fool
Fri, 08/6/10 - 07:28 am
Arqule
Jury Still Out on Exelixis's Long Term Potential
Seeking Alpha
Mon, 07/26/10 - 11:00 am
Sanofi
Novartis
GSK
Exelixis
cancer
Bristol-Myers Squibb
Arqule
ArQule says drug candidate could benefit subgroup of lung cancer patients
Yahoo/AP
Mon, 06/7/10 - 08:03 am
lung cancer
Arqule
ASCO - A Big Deal For Biotechs
Investopedia
Thu, 05/27/10 - 10:05 am
ASCO
biotech
Abbott Laboratories
Ariad Pharmaceuticals
Arqule
Bristol-Myers Squibb
Keryx
Nektar
Merck
Vanda
Aeterna Zentaris
ASCO Abstracts -- Pops and Drops!
Motley Fool
Mon, 05/24/10 - 04:30 pm
ASCO
Keryx
Ziopharm
Celldex
Arqule
Delcath
Biogen Idec
Celgene
Bristol-Myers Squibb
Arqule Joins the Phase III Club
Seeking Alpha
Wed, 04/14/10 - 07:44 am
Arqule
Tarceva
lung cancer
clinical trials
Exelixis

Pages